High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 613-619

  Baldanti, Fausto ^a   Grossi, Paolo ^a   Furione, Milena ^a   Simoncini, Lavinia ^a   Sarasini, Antonella ^a   Comoli, Patrizia ^a   Maccario, Rita ^a   Fiocchi, Roberto ^b   Gerna, Giuseppe ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC APPROACH ROUTE; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IMMUNOCOMPETENCE; INFANT; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; VIRUS INFECTION; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0033961542     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.613-619.2000     Document Type: Article

References (32)

1. Alfrey, E. J., A. L. Friedman, R. A. Grossman, L. J. Perloff, A. Naji, C. F. Barker, K. T. Montone, J. E. Tomaszewski, C. Chmielewski, T. Holland, C. Zmijewski, and D. C. Dafoe. 1992. A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation 54:250-253.
2. Armitage, J. M., R. L. Kormos, R. S. Stuart, F. J. Fricker, B. P. Griffith, M. Nalesnik, R. L. Hardesty, and J. S. Dummer. 1991. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J. Heart Lung Transplant 10:877-886.
3. Cleary, M. L., and J. Sklar. 1984. Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489-493.
4. Craig, F. E., M. L. Gulley, and P. M. Banks. 1993. Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 99:265-276.
5. Fischer, A., S. Blanche, J. Le Bidois, P. Bordigoni, J. L. Garnier, P. Niaudet, F. Morinet, F. Le Deist, A. M. Fischer, C. Griscelli, and M. Hirn. 1991. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N. Engl. J. Med. 324:1451-1456.
6. Gerna, G., M. Furione, F. Baldanti, and A. Sarasini. 1994. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J. Clin. Microbiol. 32:2709-2717.
7. Hanto, D. W., G. Frizzera, K. J. Gajl-Peczalska, K. Sakamoto, D. T. Purtilo, H. H. Balfour, Jr., R. L. Simmons, and J. S. Najarian. 1982. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med. 306:913-918.
8. Haque, T., P. L. Amlot, N. Helling, J. A. Thomas, P. Sweny, K. Rolles, A. K. Burroughs, H. G. Prentice, and D. H. Crawford. 1998. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J. Immunol. 160:6204-6209.
9. Ho, M., R. Jaffe, G. Miller, M. K. Breinig, J. S. Dummer, L. Makowka, R. W. Atchison, F. Karrer, M. A. Nalesnik, and T. E. Starzl. 1988. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45: 719-727.
10. Kenagy, D. N., Y. Schleisinger, K. Week, J. H. Ritter, M. M. Gaudreault-Keener, and G. A. Storch. 1995. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 60:547-554.
11. Knowles, D. M., E. Cesarman, A. Chadburn, G. Frizzera, J. Chen, E. A. Rose, and R. E. Michler. 1995. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552-565.
12. Locker, J., and M. Nalesnik. 1989. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am. J. Pathol. 135:977-987.
13. Lucas, K. G., R. L. Burton, S. E. Zimmerman, J. Wang, K. G. Cornetta, K. A. Robertson, C. H. Lee, and D. J. Emanuel. 1998. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654-3661.
14. Martin, P. J., H. M. Shulman, W. H. Schubach, J. A. Hansen, A. Fefer, G. Miller, and E. D. Thomas. 1984. Fatal Epstein-Barr virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann. Intern. Med. 101:310-315.
15. Nalesnik, M. A. 1996. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin. Thorac. Cardiovasc. Surg. 8:139-148.
16. Nalesnik, M. A., R. Jaffe, T. E. Starzl, A. J. Demetris, K. Porter, J. A. Burnham, L. Makowka, M. Ho, and J. Locker. 1988. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol. 133:173-192.
17. Patel, R., and C. V. Paya. 1997. Infections in solid-organ transplant recipients. Clin. Microbiol. Rev. 10:86-124.
18. Penn, I. 1991. The changing pattern of posttransplant malignancies. Transplant. Proc. 23:1101-1113.
19. Penn, I., W. Hammond, L. Brettschneider, and T. E. Starzl. 1969. Malignant lymphomas in transplantation patients. Transplant. Proc. 1:106-112.
20. Randhawa, P. S., R. S. Markin, T. E. Starzl, and A. J. Demetris. 1990. Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am. J. Surg. Pathol. 14:538-547.
21. Riddler, S. A., M. C. Breining, and J. L. McKnight. 1994. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972-984.
22. Rooney, C. M., C. A. Smith, C. Y. Ng, S. Loftin, C. Li, R. A. Krance, M. K. Brenner, and H. E. Heslop. 1995. Use of gene-modilied virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9-13
23. Rowe, D. T., L. Qu, J. Reynes, N. Jabbour, E. Yunis, P. Putnam, S. Todo, and M. Green. 1997. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 35:1612-1615.
24. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphopro-liferative disease. Blood 83:2712-2722.
25. Shapiro, R. S., A. Chauvenet, W. McGuire, A. Pearson, A. W. Craft, P. McGlave, and A. Filipovich. 1988. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin. N. Engl. J. Med. 318:1334.
26. Shapiro, R. S., K. McClain, G. Frizzera, K. J. Gajl-Peczalska, J. H. Kersey, B. R. Blazar, D. C. Arthur, D. F. Patton, J. S. Greenberg, B. Burke, N. K. C. Ramsay, P. McGlave, and A. M. Filipovich. 1988. Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234-1243.
27. Starzl, T. E., M. A. Nalesnik, K. A. Porter, M. Ho, S. Iwatsuki, B. P. Griffith, J. T. Rosenthal, T. R. Hakala, B. W. Shaw, Jr., R. L. Hardesty, R. W. Atchinson, R. Jaffe, and H. T. Bahnson. 1984. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583-587.
28. Swerdlow, S. H. 1992. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease. Histopathology 20:373-385.
29. Swinnen, L. J., M. R. Costanzo-Nordin, S. G. Fisher, E. J. O'Sullivan, M. R. Johnson, A. L. Heroux, G. J. Dizikes, R. Pifarre, and R. I. Fisher. 1990, Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N. Engl. J. Med. 323:1723-1728.
30. Telenti, A., W. F. Marshall, and T. F. Smith. 1990. Detection of Epstein-Barr virus by polymerase chain reaction. J. Clin. Microbiol. 28:2187-2190.
31. Weiss, L. M., and L. A. Mohaved. 1989. In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations. Am. J. Pathol. 134:651-659.
32. Zipeto, D., F. Baldanti, D. Zella, M. Furione, A. Cavicchini, G. Milanesi, and G. Gerna. 1993. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. J. Virol. Methods 44:45-51.